Covidien (COV) voluntarily recalls its Duet TRS tissue reinforcement system, which the company has also stopped manufacturing. Covidien has received a report that links the reinforcement material to injury after abdominal surgery. The recall follows one in January after reports of 13 serious injuries and three deaths following the application of Duet TRS in the chest area. (PR)
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Investor's Business Daily (Jan 22, 2015)
at MarketWatch.com (Jan 17, 2015)
at Nasdaq.com (Jan 13, 2015)
at CNBC.com (Jan 12, 2015)
at Investor's Business Daily (Jan 8, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs